Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Covington
Accenture
Cipla
McKesson
Citi
Mallinckrodt
Deloitte
Chubb

Generated: July 21, 2018

DrugPatentWatch Database Preview

Chymotrypsin - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for chymotrypsin and what is the scope of chymotrypsin freedom to operate?

Chymotrypsin
is the generic ingredient in three branded drugs marketed by Sola Barnes Hind, Ciba, Novartis, and Alcon, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for chymotrypsin.
Summary for chymotrypsin

US Patents and Regulatory Information for chymotrypsin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ciba CATARASE chymotrypsin FOR SOLUTION;OPHTHALMIC 016938-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sola Barnes Hind ALPHA CHYMAR chymotrypsin FOR SOLUTION;OPHTHALMIC 011837-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis CATARASE chymotrypsin FOR SOLUTION;OPHTHALMIC 018121-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alcon ZOLYSE chymotrypsin FOR SOLUTION;OPHTHALMIC 011903-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Colorcon
UBS
Fuji
Dow
Queensland Health
Julphar
AstraZeneca
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.